期刊文献+

甲钴胺治疗前庭神经炎疗效研究 被引量:3

Analysis of Therapeutic Effect of Methylcobalamin in Vestibular Neuritis
下载PDF
导出
摘要 目的:观察甲钴胺联合糖皮质激素、康复训练治疗前庭神经炎的临床疗效。方法:将61例前庭神经炎患者根据随机数字表法分为甲钴胺联合糖皮质激素、康复训练组,给予甲钴胺1mg静脉推注10d,后改为口服甲钴胺1.5mg/d,服用3个月,强的松1mg/kg,口服5d,联合康复训练;常规治疗组,强的松1mg/kg,口服5d,联合康复训练。随访期均为半年。用眩晕残障程度评定量表(DHI)评分和冷热试验半规管轻瘫(CP)进行临床疗效判定。结果:两组治疗后,1个月时DHI及CP均下降,但两组之间比较无显著性差异;在3个月时治疗组DHI较对照组下降明显,有显著性差异,CP较对照组有下降,但无统计学意义;6个月时,治疗组DHI较对照组无显著性差异,而CP较对照组有显著性差异。结论:甲钴胺联合糖皮质激素和前庭康复可以改善前庭神经炎眩晕残障程度,改善远期动态前庭失衡。 Objective: To observe the efficacy of methyleobalamin in combined with corticosteroids and vestibula reha- bilitation in the treatment of vestibular neuritis(VN). Methods: 61 patients with VN were randomly divided into the methylcobalamin group (n--31) and the control group (n= 30). The methylcobalamin group was treated with Intrave- nous Injection with methylcobalamin ling/d, and 10 days later, oral methylcobalamin 1.5mg/d, the course of treatment of methylcobalamin was 3 months. All patients were given corticosteroids(lmg/kg, for 5d) and vestibula rehabilita- tion. Follow-up period were 6 months. The efficacy was measured by Dizziness Handicap Inventory (DHI) and canal paralysis(CP). Results:DHI score and CP of both groups were all decreased after 1 month, 3 months and 6 months. There were no significant reduction in DHI score and CP after 1 month, but a significant reduction in DHI score was found after 3 months and a significant reduction in CP after 6 months. Conclusion: It is possible to improve the dizziness handicap and long-term dynamic vestibular imbalances of VN by means of methylcobalamin in combined with cortico- steroids and vestibula rehabilitation.
出处 《医学理论与实践》 2015年第23期3174-3175,3185,共3页 The Journal of Medical Theory and Practice
关键词 甲钴胺 前庭神经炎 眩晕残障程度评定量表 冷热试验 Methylcobalamin,Vestibular neuritis,Dizziness Handicap Inventory,Caloric test
  • 相关文献

参考文献15

  • 1Baloh RW,Kerber KA.Clinical Neurophysiology of the Vestibular System[M].4th ed.New York:Oxford University Press,2011.
  • 2Arbusow V,Schulz P,Strupp M,et al.Distribution of herpessimplex virus type 1in human geniculate and vestibular ganglia:implications for vestibular neuritis[J].Ann Neurol,1999,46(3):416-419.
  • 3Arbusow V,Derfuss T,Held K,et al.Latency of herpes simplex virus type-1in human geniculate and vestibular ganglia is associated with infiltration of CD8+T cells[J].Med Virol,2010,82(11):1917-1920.
  • 4Esaki S,Goshima F,Kimura H,et al.Auditory and vestibular defects induced by experimental labyrinthitis following herpes simplex virus in mice[J].Acta Otolaryngol,2011,131(7):684-691.
  • 5Brandt T.Vertigo:Its Multisensory Syndromes[M].2nd ed.London:Springer,2012.
  • 6Tselis AC,Booss J.Handbook of Clinical Neurology,Vol.123(3rd series)Neurovirology//Walter RoyalⅢand Diana Vargas.Bell’s palsy and vestibular neuronitis.Chapter 38[M].Elsevier BV,2014:763-770.
  • 7Jacobson GP,Newman CW.The development of the Dizziness Handicap Inventory[J].Archives Otolaryngology-Head Neck Surgery,1990,116(4):424-427.
  • 8丁雷,刘畅,王嘉玺,王冬梅.眩晕残障程度评定量表(中文版)的评价[J].中华耳科学杂志,2013,11(2):228-230. 被引量:229
  • 9Adolfo M,Bronstein,Thomas Lempert.Dizzines:A Practical Approach to Diagnosis and Management[M].London:Cambridge University Press,2007.
  • 10Herdman SJ.Vestibular rehabilitation[J].Curr Opin Neurol,2013,26(1):96-101.

二级参考文献23

  • 1Koh JY, Choi DW. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay[Jl. J Neurosci Methods 1987;20: 83-90.
  • 2McKeever M, Molloy A, Weir DG, Young PB, Kennedy DG,Kennedy S, et al. An abnormal methylation ratio induces hypomethylation in vitro in the brain of pig and man, but not in rat[J].Clin Sci 1995; 88: 73-79.
  • 3Pfohl-Leszkowicz A, Keith G, Dirheimer G. Effect of cobalamin derivatives on in vitro enzymatic DNA methylation: methylcobalamin can act Ks a methyl donor[J]. Biochenlistrv 1991 ;30:8045-8051.
  • 4Monyer H, Goldberg WP, Choi DW. Glucose deprivation neuronal injury in cortical culture[J]. Brain Res 1989; 483: 347-354.
  • 5Peppard RF, Martin WRW, Clark CM, Carr GD, Mcaeer PL, Calne DB. Cortical glucose metabolism in Parkirkson' s and Alzheimer' s disease[J ].J Neurosci Res 1990 : 27 : 561-568.
  • 6Kikuchi M, Kashii S, Honda Y, Tarnura Y, Kaneda K, Akaike A.Protective effects of methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell culture [J ]. Invest Ophthalmol Vis Sci 1997; 38 : 848-854.
  • 7Akaike A, Tamura Y, Sato Y, Yokota T. Protective effects of a vitamin Bl2 analog, metylcobalamin, against glutamate cytotoxicity in cultured cortical neurons[J ], Eur J Pharmacol 1993 ;241 : 1-6,.
  • 8Yaqub BA,Siddique A,Sulimani R.Effects of methylcobalamin on diabetic neuropathy[J].Clin Neurol Neurosurg,1992,94(2):105-111.
  • 9Jalaludin MA.Methylcobalamin treatment of Bell's palsy[J].Methods Find Exp Clin Pharmacol,1995,17(8):539-544.
  • 10东郁郎 湖崎弘 中谷一.口服弥可保(甲钴胺)对慢性青光眼视野的作用[J].日本眼科纪要,1983,34(4):873-878.

共引文献260

同被引文献26

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部